MX2012001178A - Composicion que consta de un material polimerico anionico y la sal de un acido monocarboxilico saturado que tiene 6 a 22 atomos de carbono. - Google Patents

Composicion que consta de un material polimerico anionico y la sal de un acido monocarboxilico saturado que tiene 6 a 22 atomos de carbono.

Info

Publication number
MX2012001178A
MX2012001178A MX2012001178A MX2012001178A MX2012001178A MX 2012001178 A MX2012001178 A MX 2012001178A MX 2012001178 A MX2012001178 A MX 2012001178A MX 2012001178 A MX2012001178 A MX 2012001178A MX 2012001178 A MX2012001178 A MX 2012001178A
Authority
MX
Mexico
Prior art keywords
composition
polymeric material
carbon atoms
salt
saturated monocarboxylic
Prior art date
Application number
MX2012001178A
Other languages
English (en)
Inventor
Erna Roth
Ruediger Alexowsky
Hans-Ulrich Petereit
Original Assignee
Evonik Roehm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Roehm Gmbh filed Critical Evonik Roehm Gmbh
Publication of MX2012001178A publication Critical patent/MX2012001178A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/20—Compounding polymers with additives, e.g. colouring
    • C08J3/205—Compounding polymers with additives, e.g. colouring in the presence of a continuous liquid phase
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2333/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
    • C08J2333/02—Homopolymers or copolymers of acids; Metal or ammonium salts thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2333/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
    • C08J2333/04—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers esters
    • C08J2333/06—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers esters of esters containing only carbon, hydrogen, and oxygen, the oxygen atom being present only as part of the carboxyl radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)

Abstract

La invención trata sobre una composición para recubrir o fijar principios activos farmacéuticos, nutracéuticos o cosméticos, que consta de a) un material polimérico aniónico, y b) una o más sales de ácidos monocarboxílicos saturados que tienen 6 a 22 átomos de carbono, que se caracterizan porque la cantidad de sales de los ácidos monocarboxílicos en la composición corresponden a 3 - 50 mol por ciento de la cantidad de grupos aniónicos en el material polimérico. La invención también trata sobre un proceso para preparar una dispersión de la composición, así como también el uso de dicha composición en formas de dosificación sólidas de recubrimiento entérico.
MX2012001178A 2009-07-30 2009-07-30 Composicion que consta de un material polimerico anionico y la sal de un acido monocarboxilico saturado que tiene 6 a 22 atomos de carbono. MX2012001178A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2009/059860 WO2011012163A1 (en) 2009-07-30 2009-07-30 Composition comprising an anionic polymeric material and the salt of a saturated monocarboxylic acid having 6 to 22 carbon atoms

Publications (1)

Publication Number Publication Date
MX2012001178A true MX2012001178A (es) 2012-03-07

Family

ID=42126461

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012001178A MX2012001178A (es) 2009-07-30 2009-07-30 Composicion que consta de un material polimerico anionico y la sal de un acido monocarboxilico saturado que tiene 6 a 22 atomos de carbono.

Country Status (10)

Country Link
US (1) US20120093904A1 (es)
EP (1) EP2459177A1 (es)
JP (1) JP2013500280A (es)
KR (1) KR20120047243A (es)
CN (1) CN102470112A (es)
BR (1) BR112012002093A2 (es)
CA (1) CA2769153A1 (es)
IL (1) IL216343A0 (es)
MX (1) MX2012001178A (es)
WO (1) WO2011012163A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101799624B1 (ko) * 2011-06-17 2017-11-20 에보니크 룀 게엠베하 제약 또는 기능식품 투여 형태에 적합한 코팅 조성물
JP6254719B2 (ja) * 2014-04-08 2017-12-27 ダウ グローバル テクノロジーズ エルエルシー エステル化セルロースエーテルを含む分散体
KR20180034479A (ko) * 2015-07-28 2018-04-04 다우 글로벌 테크놀로지스 엘엘씨 에스테르화된 셀룰로오스 에테르를 포함하는 분산물
US11980218B2 (en) 2018-06-27 2024-05-14 Basf Se Dust-free cold-water-dispersible preparations
AU2022308614A1 (en) 2021-07-09 2024-02-22 Evonik Operations Gmbh Hard shell capsules having improved colon release

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS608373A (ja) * 1983-06-29 1985-01-17 Showa Shell Sekiyu Kk 二液型瞬間固化性被覆用組成物
AU674684B2 (en) * 1992-07-20 1997-01-09 Sterno Group LLC, The Gelled organic liquids
JP3017906B2 (ja) * 1993-10-08 2000-03-13 信越化学工業株式会社 腸溶性コーティング剤分散液
JP3355593B2 (ja) * 1994-08-19 2002-12-09 信越化学工業株式会社 固形腸溶製剤の製造方法
DE9414065U1 (de) * 1994-08-31 1994-11-03 Roehm Gmbh Thermoplastischer Kunststoff für darmsaftlösliche Arznei-Umhüllungen
JPH0931370A (ja) * 1995-07-19 1997-02-04 Shin Etsu Chem Co Ltd 固形製剤のコーティング剤
WO2000006128A1 (fr) * 1998-07-28 2000-02-10 Tanabe Seiyaku Co., Ltd. Preparation capable de liberer un medicament au niveau d'un site cible dans l'intestin
US6420473B1 (en) * 2000-02-10 2002-07-16 Bpsi Holdings, Inc. Acrylic enteric coating compositions
KR20030025903A (ko) * 2000-02-10 2003-03-29 비피에스아이 홀딩스, 인코포레이션. 아크릴 장용 코팅 조성물
JP2002047184A (ja) * 2000-05-23 2002-02-12 Takeda Chem Ind Ltd チオフェン誘導体含有医薬組成物
US6756116B2 (en) * 2002-02-14 2004-06-29 E. I. Du Pont De Nemours And Company Surface treatment of ethylene-based polymer pellets to improve blocking resistance
US20040213847A1 (en) * 2003-04-23 2004-10-28 Matharu Amol Singh Delayed release pharmaceutical compositions containing proton pump inhibitors
CN1938026A (zh) * 2004-03-26 2007-03-28 卫材R&D管理有限公司 控释制剂及其制造方法
US20080096979A1 (en) * 2004-11-08 2008-04-24 Rubicon Research Pvt. Ltd. Aqueous Pharmaceutical Coating
JP4894298B2 (ja) * 2005-02-28 2012-03-14 住友化学株式会社 積層体の製造方法

Also Published As

Publication number Publication date
BR112012002093A2 (pt) 2017-09-12
CN102470112A (zh) 2012-05-23
EP2459177A1 (en) 2012-06-06
IL216343A0 (en) 2012-01-31
US20120093904A1 (en) 2012-04-19
JP2013500280A (ja) 2013-01-07
CA2769153A1 (en) 2011-02-03
WO2011012163A1 (en) 2011-02-03
KR20120047243A (ko) 2012-05-11

Similar Documents

Publication Publication Date Title
MX2010006371A (es) Producto para el cuidado oral y metodos de uso y fabricacion del mismo.
JO2745B1 (en) Process for the preparation and uses of a filler product of processed metal salts
WO2012164065A3 (en) Process for treating straightened keratin fibres
MY148258A (en) Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments
MX337891B (es) Papel tisu antimicrobiano y proceos para elaborar el mismo.
MX2012001178A (es) Composicion que consta de un material polimerico anionico y la sal de un acido monocarboxilico saturado que tiene 6 a 22 atomos de carbono.
MX354543B (es) Composicion esterilizada que comprende al menos un acido hialuronico y ascorbilo fosfato de magnesio.
EP2380850A4 (en) MODIFIED SODIUM MONTMORILLONITE, PREPARATION METHOD AND USE
MY148096A (en) 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments
MY168425A (en) New coated controlled release active agent carriers
MX2011013969A (es) Aditivo hidrofobico para utilizarlo con tela, fibra y pelicula.
WO2008089151A3 (en) High dose film compositions and methods of preparation
NZ610346A (en) Hyaluronic acid based formulations
WO2013071131A3 (en) Organophosphorous, multivalent metal compounds, and bioactive glass material macromolecular network compositions and methods
TN2011000370A1 (en) Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof
EP2528578A4 (en) DENTAL COMPOSITION USING A CALCIUM SOURCE
MY156440A (en) Waterborne coating composition comprising a polyester and a metal salt of a fatty acid
MX340732B (es) Composicion secuestrante de calcio.
WO2010125323A8 (en) Biocidal composition
MY161620A (en) Oral care formulations that enhance amount of soluble zinc
TR201909466T4 (tr) Düşük serbest stearik asit içeren veya tespit edilebilen hiç serbest stearik asit içermeyen, stearik asitle işlenmiş kalsiyum karbonat bileşimleri ve ilgili yöntemler.
MX2015017854A (es) Composicion que comprende glutamico-n, n-diacetato (glda), agua y enzima.
NZ586423A (en) Liver function-protecting agent comprising a phospholipid
MX2011010547A (es) Composiciones farmaceuticas estables de diclofenaco.
MX2015017866A (es) Formulacion detergente higroscopica que comprende un quelatador de aminocarboxilato e ingredientes sensibles a la humedad.